The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 15,901–16,000 of 31,469
Ko, J. M., Park, H. K., Yang, S., & Hwang, I. T. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0080 · Cited by 19
Shin, H. S., Lee, W., Kim, S.-W., Jung, C., Rhee, E., Kim, B. J., Sung, K., Kim, B., Kang, J.-H., Lee, M., et al. (2005) · Circulation Journal · doi:10.1253/circj.69.409 · Cited by 19
Glucose Tolerance Predicts Short-term Refeeding Outcome in Females With Anorexia Nervosa
Yasuhara, D., Naruo, T., Nagai, N., Muranaga, T., Nakahara, T., Tanaka, M., Kojima, S., Sagiyama, K.-I., Masuda, A., & Inui, A. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000170332.47378.a1 · Cited by 19
VANDERVLEUTEN, G., Veerkamp, M. J., VANTITS, L., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.019 · Cited by 19
Katakura, M., Komatsu, M., Sato, Y., Hashizume, K., & Aizawa, T. (2004) · Metabolism · doi:10.1016/j.metabol.2004.02.024 · Cited by 19
Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1
Panz, V. R., Bonegio, R. G. B., Raal, F. J., et al. (2002) · Transplantation · doi:10.1097/00007890-200202270-00019 · Cited by 19
An update on cardiovascular risk of metabolic syndrome
Rosenbaum, P., & Ferreira, S. R. G. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000300004 · Cited by 19
Shin, H. D., Kim, L. H., Park, B. L., Jung, H. S., Cho, Y. M., Moon, M. K., Lee, H. K., & Park, K. S. (2003) · Human Mutation · doi:10.1002/humu.9168 · Cited by 17
Leonetti, F., Iacobellis, G., Zappaterreno, A., Ribaudo, M. C., Tiberti, C., Vecci, E., & Mario, U. D. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80027-9 · Cited by 20
LH Dynamics in Overweight Girls with Premature Adrenarche and Slowly Progressive Sexual Precocity
Bordini, B., Littlejohn, E., & Rosenfield, R. L. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-724696 · Cited by 19
Moran, L., Meyer, C., Hutchison, S. K., Zoungas, S., & Teede, H. J. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345790 · Cited by 19
Troglitazone Stimulates Pancreatic Growth in Normal Rats
Jia, D. M., & Otsuki, M. (2002) · Pancreas · doi:10.1097/00006676-200204000-00015 · Cited by 19
Parker, E., Phillips, D. I. W., Cockington, R. A., Cull, C. A., & Poulton, J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00600.2004 · Cited by 19
Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica
Papapietro, K., Emma Díaz, G., Attila Csendes, J., et al. (2005) · Revista médica de Chile · doi:10.4067/s0034-98872005000500001 · Cited by 19
Postprandial triglycerides in response to high fat: role of dietary carbohydrate
Kriketos, A. D., Sam, W., Schubert, T., Maclean, E., & Campbell, L. V. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01159.x · Cited by 19
Ersöz, H. Ö., Ükinç, K., Baykan, M., Erem, C., Durmuş, İ., Hacıhasanoğlu, A., & Telatar, M. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802574 · Cited by 19
Glueck, C. J., Lang, J. E., Tracy, T., Sieve-Smith, L., & Wang, P. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90156-7 · Cited by 19
Ono, M., Ikegami, H., Fujisawa, T., Nojima, K., Kawabata, Y., Nishino, M., Taniguchi, H., Itoi‐Babaya, M., Babaya, N., Inoue, K., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2004.11.007 · Cited by 19
Nishizawà, Y., Shoji, T., Emoto, M., et al. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.06.018 · Cited by 19
Luzi, L., Meneghini, E., Oggionni, S., Tambussi, G., Piceni-Sereni, L., & Lazzarin, A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02039 · Cited by 19
Coates, P. A., Ollerton, R. L., Luzio, S. D., Ismail, I. S., & Owens, D. R. (1993) · Diabetes · doi:10.2337/diab.42.11.1635 · Cited by 19
Heideman, W. H., Nierkens, V., Stronks, K., Middelkoop, B. J., Twisk, J. W. R., Verhoeff, A. P., de Wit, M., & Snoek, F. J. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-751 · Cited by 19
Rawat, A., Gangwar, A. K., Tiwari, S., Kant, S., Garg, R. K., & Singh, P. K. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_400_19 · Cited by 18
“4).[17] The Statistical Package for Social Sciences (SPSS) (IBM SPSS Statistics, Armonk, NY, USA), version 21 was used for data analysis.”
Wedick, N. M., Snijder, M. B., Dekker, J. M., Heine, R. J., Stehouwer, C. D. A., Nijpels, G., & van Dam, R. M. (2009) · Obesity · doi:10.1038/oby.2008.666 · Cited by 18
Abo-Elmatty, D. M., & Mehanna, E. T. (2019) · Biochemical Genetics · doi:10.1007/s10528-018-9886-1 · Cited by 18
Exercise Adherence in Hispanic Adolescents with Obesity or Type 2 Diabetes
Faulkner, M. S., & Michaliszyn, S. F. (2021) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2020.09.012 · Cited by 18
“Insulin resistance was calculated by the Homeostasis Model Assessment (HOMA-IR) method (Matthews et al., 1985).”
MethodOuerghi, N., Ben Fradj, M. K., Talbi, E., Bezrati, I., Feki, M., & Bouassida, A. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155170 · Cited by 17
Maldonado‐González, M., Nazará, Z., Torres‐Castillo, N., Martínez‐López, E., la Cruz-Color, L. D., & Ruiz‐Madrigal, B. (2022) · Nutrients · doi:10.3390/nu14224726 · Cited by 18
Lopez‐Yus, M., Casamayor, C., Soriano-Godes, J. J., Ansón, S. B., Gonzalez-Irazabal, Y., García-Sobreviela, M. P., Garcia-Rodriguez, B., del Moral, R., Calmarza, P., Artigas, J. M., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02075-0 · Cited by 20
Lakić, B., Škrbić, R., Uletilović, S., Mandić-Kovačević, N., Grabež, M., Šarić, M. P., Stojiljković, M. P., Soldatović, I., Janjetović, Z., Stokanović, A., et al. (2024) · Journal of Diabetes Research · doi:10.1155/2024/4187796 · Cited by 24
Nielsen, M. H., Nøhr-Meldgaard, J., Møllerhøj, M. B., Oró, D., Pors, S. E., Andersen, M. W., Kamzolas, I., Petsalaki, E., Vacca, M., Harder, L. M., et al. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00110.2024 · Cited by 20
Saber, S., & Mirgani, S. M. (2025) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-025-00608-y · Cited by 18
Horner, D., Jahn, M., Bønnelykke, K., Chawes, B., Flensborg‐Madsen, T., Schoos, A. M., Stokholm, J., & Rasmussen, M. A. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041486 · Cited by 28
Saber, S., & Solouma, E. M. (2025) · Indian Journal of Physics · doi:10.1007/s12648-025-03712-y · Cited by 18
Cross-sectional analysis of visceral adipose tissue associations with obesity-related disease
Potter, A. W., & Friedl, K. E. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.07.023 · Cited by 21
Gibson, C. D., Atalayer, D., Flancbaum, L., & Geliebter, A. (2012) · PubMed · Cited by 18
Reichenbach, Z. W., Sloan, J. A., Rizvi-Toner, A., et al. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.07.023 · Cited by 18
Díaz‐Rúa, R., García-Ruiz, E., Caimari, A., Palou, A., & Oliver, P. (2014) · Food & Function · doi:10.1039/c4fo00429a · Cited by 18
Chilelli, N. C., Cosma, C., Ragazzi, E., Burlina, S., Zaninotto, M., Plebani, M., & Lapolla, A. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0639-2 · Cited by 18
Improvement of pulmonary function with arm swing exercise in patients with type 2 diabetes
Tunkamnerdthai, O., Auvichayapat, P., Donsom, M., & Leelayuwat, N. (2015) · Journal of Physical Therapy Science · doi:10.1589/jpts.27.649 · Cited by 20
Pickavance, L. C., & Wilding, J. P. H. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00586.x · Cited by 18
Iliadis, F. S., Kadoglou, N. P. E., Hatzitolios, A. I., Karamouzis, M. V., Alevizos, M., & Karamitsos, D. T. (2007) · PubMed · Cited by 18
Lin, C.-H., Hsieh, S., Sun, J., Tsai, J.-S., & Huang, Y. (2015) · Scientific Reports · doi:10.1038/srep16968 · Cited by 19
Midaoui, A. E. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000556 · Cited by 18
Michaud, A., Grenier–Larouche, T., Caron‐Dorval, D., Marceau, S., Biertho, L. D., Simard, S., Richard, D., Tchernof, A., & Carpentier, A. C. (2017) · Metabolism · doi:10.1016/j.metabol.2017.06.005 · Cited by 18
Durnwald, C. P., Downes, K. L., Leite, R., Elovitz, M. A., & Parry, S. I. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2958 · Cited by 19
An insulin resistance associated neural correlate of impulsivity in type 2 diabetes mellitus
Eckstrand, K., Mummareddy, N., Kang, H., Cowan, R. L., Zhou, M., Zald, D. H., Silver, H. J., Niswender, K. D., & Avison, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189113 · Cited by 20
Android fat as a determinant of metabolic syndrome: Sex differences
Bi, X., Loo, Y. T., & Henry, C. J. (2018) · Nutrition · doi:10.1016/j.nut.2018.05.016 · Cited by 18
Prodhan, U. K., Milan, A. M., Thorstensen, E. B., Barnett, M. P. G., Stewart, R., Benatar, J. R., & Cameron‐Smith, D. (2018) · Nutrients · doi:10.3390/nu10101510 · Cited by 18
Gilbertson, N. M., Mandelson, J. A., Hilovsky, K. L., Akers, J. D., Hargens, T. A., Wenos, D. L., & Edwards, E. S. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04137-2 · Cited by 18
Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally
Köninger, A., Iannaccone, A., Hajder, E., Frank, M., Schmidt, B., Schleußner, E., Kimmig, R., Gellhaus, A., & Dieplinger, H. (2019) · Endocrine Connections · doi:10.1530/ec-19-0064 · Cited by 18
Godzień, J., Kałaska, B., Adamska-Patruno, E., et al. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.04.053 · Cited by 18
Hamady, S., Ghanem, H., Abdel‐Ghaffar, A., Metwaly, F. G., Hanafy, L. K., & Ahmed, E. K. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1628069 · Cited by 18
Tarantino, G., Citro, V., Conforti, P., Balsano, C., & Capone, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101510 · Cited by 19
Quirarte-Báez, S. M., Zamora-Pérez, A. L., Estrada, C. A. R., et al. (2019) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.15586/jptcp.v26i4.634 · Cited by 18
Bianchi, A. C., Pomar, A. P., Jiménez-Segovia, M., Martínez-Córcoles, J. A., & González-Argente, X. F. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04777-w · Cited by 20
Nonfunctional adrenal incidentalomas may be related to bisphenol-A
Eker, F., Güngüneş, A., Durmaz, Ş. A., Kısa, Ü., & Celik, Z. R. (2020) · Endocrine · doi:10.1007/s12020-020-02502-2 · Cited by 18
Insulin Resistance in Congenital Adrenal Hyperplasia is Compensated for by Reduced Insulin Clearance
de Oliveira, D. M., Tura, A., Vasques, A. C. J., Camilo, D. F., Lima, M. M. D. O., de Lemos‐Marini, S. H. V., Gonçalves, E. M., Guerra‐Júnior, G., & Geloneze, B. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab010 · Cited by 18
Increased Prolactin is an Adaptive Response to Protect Against Metabolic Disorders in Obesity
Liu, J., Wang, Q., Zhang, L., Fu, J., An, Y., Meng, H., & Wang, G. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.002 · Cited by 19
Méndez-Frausto, G., Romero-Aguilera, G., Sánchez-Gutiérrez, R., García-Jacobo, R. E., Lara-Ramirez, E. E., Uresti‐Rivera, E. E., González‐Amaro, R., Enciso‐Moreno, J. A., & García-Hernández, M. H. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108692 · Cited by 18
Mirmiranpour, H., Bathaie, S. Z., Khaghani, S., et al. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-00931-x · Cited by 18
Obesity and Prevalence of Latent Tuberculosis: A Population-Based Survey
Badawi, A. F., & Liu, C. J. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/1178633721994607 · Cited by 18
Huo, Y., Cheng, L., Wang, C., Deng, Y., Hu, R., Shi, L., Wan, Q., Chen, L., Zeng, T., Yu, X., et al. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13176 · Cited by 18
Kim, Y., Kang, H., & Lee, D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052561 · Cited by 18
Conte, M., Santoro, A., Collura, S., et al. (2021) · Aging · doi:10.18632/aging.202840 · Cited by 18
Ravi, R., Kalra, J. K., Srinivasan, R., et al. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.3.983 · Cited by 18
Zhang, W., Sun, Q., Chen, B., Basta, M., Chong-tao, X., & Li, Y. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.03.030 · Cited by 20
van der Haar, S., Hoevenaars, F. P. M., van den Brink, W. J., van den Broek, T., Timmer, M., Boorsma, A., & Doets, E. L. (2021) · JMIR Formative Research · doi:10.2196/25043 · Cited by 18
Dietary patterns acquired in early life are associated with cardiometabolic markers at school age
Luque, V., Closa‐Monasterolo, R., Grote, V., Ambrosini, G. L., Zaragoza-Jordana, M., Ferré, N., Theurich, M. A., Koletzko, B. V., Verduci, E., Gruszfeld, D., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.06.001 · Cited by 19
Barragán-Zarate, G. S., Alexander-Aguilera, A., Lagunez-Rivera, L., Solano, R., & Soto-Rodríguez, I. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114376 · Cited by 19
Kazé, A. D., Musani, S. K., Correa, A., Bertoni, A. G., Golden, S. H., Abdalla, M., & Echouffo-Tcheugui, J. B. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002920 · Cited by 18
Francisqueti‐Ferron, F. V., Ferron, A. J. T., Altomare, A., Garcia, J. L., Moreto, F., Ferreira, A. L. A., Minatel, I. O., Aldini, G., & Corrêa, C. R. (2021) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2021-0002 · Cited by 18
FGF21/adiponectin ratio predicts deterioration in glycemia: a 4.6-year prospective study in China
Liu, D., Wu, L., Gao, Q., Long, X., Hou, X., Qian, L., Ni, J., Fang, Q., Li, H., & Jia, W. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01351-1 · Cited by 19
Mohamed, R. A., Abdallah, D. M., El-Brairy, A. I., Ahmed, K. A., & El-Abhar, H. S. (2021) · Molecules · doi:10.3390/molecules26165068 · Cited by 18
Paracha, A. I., Haroon, Z. H., Aamir, M., & Bibi, A. (2021) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2021.09.1015 · Cited by 20
Li, Y., & Xu, Z. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1544-8181 · Cited by 19
Acosta‐Manzano, P., Leopold‐Posch, B., Simmons, D. S., Devlieger, R., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Harreiter, J., Kautzky‐Willer, A., et al. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16945 · Cited by 18
Doma, K. M., olinar, K. F., Ramdath, D. D., Wolever, T. M. S., & Duncan, A. M. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab323 · Cited by 19
Fanelli, E., Daga, F. A., Pappaccogli, M., Eula, E., Astarita, A., Mingrone, G., Fasano, C., Magnino, C., Schiavone, D., Rabbone, I., et al. (2021) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2021-0092 · Cited by 18
Okawa, M. C., Cochran, E. K., Lightbourne, M., & Brown, R. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab782 · Cited by 19
Anthropometric measurements and serum TNF-α, IL-6 and adiponectin in type 2 diabetes
Yalçın, T., Oğuz, S., Bayraktar, M., & Rakıcıoğlu, N. (2021) · Diabetology International · doi:10.1007/s13340-021-00553-y · Cited by 19
Takei, Y., Tomiyama, H., Tanaka, N., Yamashina, A., & Chikamori, T. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0549 · Cited by 19
Liu, W., Zhang, X., Li, G., Tang, L., Zhu, P., Rios, R. S., Zheng, K. I., Ma, H., Wang, X., Pan, Q., et al. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0301 · Cited by 18
Borer, K. T., Lin, P., & Wuorinen, E. C. (2021) · Nutrients · doi:10.3390/nu13124342 · Cited by 18
Magnesium Lithospermate B Attenuates High-Fat Diet-Induced Muscle Atrophy in C57BL/6J Mice
Cheng, T., Lin, Z., Liao, K., Huang, W.-C., Jhuo, C., Pan, P., Chen, C., Kuan, Y., & Chen, W. (2021) · Nutrients · doi:10.3390/nu14010104 · Cited by 18
Micielska, K., Flis, M., Kortas, J. A., Rodziewicz-Flis, E. A., Antosiewicz, J., Wochna, K., Lombardi, G., & Ziemann, E. (2021) · Nutrients · doi:10.3390/nu13124393 · Cited by 19
Presti, R. M., Yeh, E., Williams, B., LANDAY, A. L., Jacobson, J. M., Wilson, C. C., Fichtenbaum, C. J., Utay, N. S., Dubé, M. P., Klingman, K. L., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab550 · Cited by 20
Ahmed, H. H., Kotob, S. E., Abdrabou, A., Aglan, H. A., & Elmegeed, G. A. (2021) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2274 · Cited by 18
Cohen, C. C., Francis, E. C., Perng, W., Sauder, K. A., Scherzinger, A. L., Sundaram, S. S., Shankar, K., & Dabelea, D. (2022) · Pediatric Obesity · doi:10.1111/ijpo.12902 · Cited by 18
Hao, Z., Sun, Y., Li, G., Shen, Y., Wen, Y., & Liu, Y. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00949-0 · Cited by 18
Chevli, P. A., Mehta, A., Allison, M., Ding, J., Nasir, K., Blaha, M. J., Blankstein, R., Talegawkar, S. A., Kanaya, A. M., Shapiro, M. D., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac102 · Cited by 17
Increased liver fat associates with severe metabolic perturbations in low birth weight men
Brøns, C., Thuesen, A. C. B., Elingaard-Larsen, L. O., Justesen, L., Jensen, R. T., Henriksen, N. S., Juel, H. B., Størling, J., Ried‐Larsen, M., Sparks, L. M., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1221 · Cited by 18
Younis, H. Y., Thanoon, I. A. J., Fadhil, N. N., et al. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00198 · Cited by 18
Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population
Tsirona, S., Katsaros, F., Bargiota, Α., Pοlyzos, S. A., Arapoglou, G., & KOUKOULIS, G. N. (2016) · HORMONES · doi:10.1007/bf03401407 · Cited by 18
Hsia, T.-I., Huang, P., Chen, H., Lo, Y. C., Chang, W., Jou, Y., & Huang, H.-B. (2022) · Environment International · doi:10.1016/j.envint.2022.107316 · Cited by 19
Reutrakul, S., Martyn-Nemeth, P. A., Quinn, L. T., Rydzon, B., Priyadarshini, M., Danielson, K. K., Baron, K. G., & Duffecy, J. L. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01076-2 · Cited by 20
Jones, B. J., BURADE, V. S., Akalestou, E., Manchanda, Y., Ramchunder, Z., Carrat, G., Nguyen‐Tu, M., Marchetti, P., Piemonti, L., Leclerc, I., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14794 · Cited by 17
The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS
Li, X., Yang, D., Pan, P., Azziz, R., Yang, D., Cheng, Y., & Zhao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873726 · Cited by 18
Siqueira, J. S., Vieira, T. A., Nakandakare-Maia, E. T., Palacio, T. L. N., Sarzi, F., Garcia, J. L., de Paula, B. H., Bazan, S. G. Z., Baron, G., Tucci, L., et al. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111721 · Cited by 18
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
